drugset / Trial / NCT00329914

Does Progesterone Prevent Very Preterm Delivery in Twin Pregnancies?

NCT00329914

RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of the study is to determine whether a daily dose of 200 mg progesterone administered vaginally from 20-23 to 34 weeks' gestation will reduce the rate of preterm delivery amongst twin pregnancies.

Timeline

Start
2006-06
Primary completion
2009-02
Completion
2010-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Progesterone Other / unclassified 200 mg Intravenous

Indications

No indication recorded.